Search Results for "Roche Florence Gmp"
Matching Channels
Roche is the 5th largest pharmaceutical company in the world, based on annual sales, which were recorded at $36,017m in 2009. The pharmaceutical products of Roche are major players in the followin...
Digoxin Globulin ovine Fab Roche
Interleukin-2 receptor Mab rDNA Roche
Top 50 Biopharma Products 2011
Ronald A. Rader, president of the Biotechnology Information Institute provided Contract Pharma a list of the Top 57 Biopharma Products by 2011 revenues (in millions). Mr. Rader subscribes to the sam...
Matching News
Yvonne Florence Stedman developed an interest in sexual health after a spell in general practice. Appointed consultant in contraception in 1994 in Worcestershire, she worked to make the service......
University of Florence professor awarded ESCEO-IOF Servier Pierre D. Delmas Prize
Today, at the opening of the European Congress on Osteoporosis & Osteoarthritis in Rome, Italy, Professor Maria Luisa Brandi MD, Professor of Endocrinology and Metabolic Diseases at the University of...
SOS campaign backed by Florence Nightingale Foundation
The Florence Nightingale Foundation has become the latest organisation to give its backing to our new Speak Out Safely campaign.
Partnering with Roche: Think Roche, Think Partnering
Roche is a top pharma company active in partnering, licensing and M&A in pharmaceuticals and biotechology. Roche has an active partnering group that recognizes the significant role played by 3rd p...
AES honors University of Florence neuroscientist with Epilepsy Research Recognition Award
Renzo Guerrini, M.D., Director and Professor of Pediatric Neurology and Psychiatry, Department of Neuroscience, University of Florence, Anna Meyer Children's Hospital, Italy, has been named recipient...
Hemakim, Florence Nightingale in Intercept Blood system supply agreement
Hemakim, Cerus' distributor for Turkey, has entered into a collaboration agreement to supply its Intercept Blood system to Florence Nightingale Hospital Group.
Roche CEO: No new buyout bid for Illumina
Illumina will not receive a new purchase offer from Roche Holding, Roche CEO Severin Schwan told Der Sonntag. -More-
Roche Agree To Release All Trial Data On Tamiflu Drug
The BMJ can reveal that following over three years of talks with pharmaceutical giant Roche, the Cochrane Collaboration is at last being granted access to "all 74 Roche-sponsored trials" of the influe...
Matching PubMed Articles
Risk of second primary melanoma: how should be long follow-up? Ratio of observed and expected cases.
Smoking habits among university students in Florence: Is a medical degree course the right choice?
Mosaic pigmentation disorders and associated syndromes.
On the multiple-procedure approach to body contouring in the massive weight loss patient.
